COVID-19 vaccination: The road ahead

DM Altmann, RJ Boyton - Science, 2022 - science.org
A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge
role in efforts to bring the COVID-19 pandemic under control, even though inequitable …

Antiviral approaches against influenza virus

R Kumari, SD Sharma, A Kumar, Z Ende… - Clinical microbiology …, 2023 - journals.asm.org
Preventing and controlling influenza virus infection remains a global public health
challenge, as it causes seasonal epidemics to unexpected pandemics. These infections are …

2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …

Writing Committee, TJ Gluckman, NM Bhave… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of develo** documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex

M Patone, XW Mei, L Handunnetthi, S Dixon… - Circulation, 2022 - ahajournals.org
Background: Myocarditis is more common after severe acute respiratory syndrome
coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and …

[HTML][HTML] COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated …

K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips… - Vaccine, 2024 - Elsevier
Abstract Background The Global COVID Vaccine Safety (GCoVS) Project, established in
2021 under the multinational Global Vaccine Data Network™(GVDN®), facilitates …

[HTML][HTML] Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases

HL Wong, M Hu, CK Zhou, PC Lloyd, KL Amend… - The Lancet, 2022 - thelancet.com
Background Several passive surveillance systems reported increased risks of myocarditis or
pericarditis, or both, after COVID-19 mRNA vaccination, especially in young men. We used …

Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis

A Barmada, J Klein, A Ramaswamy, NN Brodsky… - Science …, 2023 - science.org
Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including
after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular …

SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents

Ø Karlstad, P Hovi, A Husby, T Härkänen… - JAMA …, 2022 - jamanetwork.com
Importance Reports of myocarditis after SARS-CoV-2 messenger RNA (mRNA) vaccination
have emerged. Objective To evaluate the risks of myocarditis and pericarditis following …

Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus …

B Heidecker, N Dagan, R Balicer… - European journal of …, 2022 - Wiley Online Library
Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors,
recombinant protein, and inactivated virus have been administered worldwide. Although …

Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice

J Wang, W Lu, J Zhang, Y Du, M Fang, A Zhang… - Nature …, 2024 - nature.com
Viral myocarditis, an inflammatory disease of the myocardium, is a significant cause of
sudden death in children and young adults. The current coronavirus disease 19 pandemic …